Comparison of the oestrogen and progesterone receptor status in primary breast carcinomas as evaluated by immunohistochemistry and immunocytochemistry: A consecutive series of 267 patients

Cytopathology

Volumn 24, Issue 1, 2013, Pages 21-25

  Domanski, A M ^a   Monsef, N ^b   Domanski, H A ^a   Grabau, D ^a   Ferno M ^c  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^c LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER TISSUE; COMPARATIVE STUDY; CONTROLLED STUDY; FINE NEEDLE ASPIRATION BIOPSY; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

AGED; BREAST NEOPLASMS; CYTODIAGNOSIS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM GRADING; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STAINING AND LABELING; TUMOR MARKERS, BIOLOGICAL;

EID: 84872677260     PISSN: 09565507     EISSN: 13652303     Source Type: Journal    
DOI: 10.1111/j.1365-2303.2012.00997.x     Document Type: Article

References (18)

1. Zwart W, Theodorou V, Carroll JS. Estrogen receptor-positive breast cancer: a multidisciplinary challenge. Wiley Interdiscip Rev Syst Biol Med 2011;3:216-30.
2. Thompson AM, Jordan LB, Quinlan P et al. Prospective comparison of switches in biomarker status between primary and recurrent breast cancer: the Breast Recurrence In Tissues Study (BRITS). Breast Cancer Res 2010;12:R92.
3. Lindström L, Howell S, Åström G, Wilking U, Lidbrink E. Controversies in the management of metastatic breast cancer: biologic evaluation of breast cancer - should metastases be biopsied?. Educational Book, American Society of Clinical Oncoloy, http://wwwascoorg, 2010.
4. Scimia M. ThinPrep pap test: a platform for gynecological diagnosis. Adv Clin Pathol 2001;5:183-4.
5. Zhu J, Norman I, Elfgren K et al. A comparison of liquid-based cytology and Pap smear as a screening method for cervical cancer. Oncol Rep 2007;18:157-60.
6. Kontzoglou K, Moulakakis KG, Konofaos P et al. The role of liquid-based cytology in the investigation of breast lesions using fine-needle aspiration: a cytohistopathological evaluation. J Surg Oncol 2005;1:89.
7. Nasuti JF, Tam D, Gupta PK. Diagnostic value of liquid-based (Thinprep) preparations in nongynecologic cases. Diagn Cytopathol 2001;24:137-41.
8. Nigro K, Tynski Z, Wasman J, Abdul-Karim F, Wang N. Comparison of cell block preparation methods for nongynecologic ThinPrep specimens. Diagn Cytopathol 2007;35:640-3.
9. Konofaos P, Kontzoglou K, Georgoulakis J et al. The role of ThinPrep cytology in the evaluation of estrogen and progesterone receptor content of breast tumors. Surg Oncol 2006;15:257-66.
10. Leung SW, Bedard YC. Estrogen and progesterone receptor contents in ThinPrep-processed fine-needle aspirates of breast. Am J Clin Pathol 1999;112:50-6.
11. Tabbara SO, Sidawy MK, Frost AR et al. The stability of estrogen and progesterone receptor expression on breast carcinoma cells stored as PreservCyt suspensions and as ThinPrep slides. Cancer 1998;84:355-60.
12. Tafjord S, Bohler PJ, Risberg B, Torlakovic E. Estrogen and progesterone hormone receptor status in breast carcinoma: comparison of immunocytochemistry and immunohistochemistry. Diagn Cytopathol 2002;26:137-41.
13. Sauer T, Ebeltoft K, Pedersen MK, Karesen R. Liquid based material from fine needle aspirates from breast carcinomas offers the possibility of long-time storage without significant loss of immunoreactivity of estrogen and progesterone receptors. Cytojournal 2010;7:24.
14. Michael CW, Hunter B. Interpretation of fine-needle aspirates processed by the ThinPrep technique: cytologic artifacts and diagnostic pitfalls. Diagn Cytopathol 2000;23:6-13.
15. Masood S, Frykberg ER, McLellan GL, Bullard JB. Application of estrogen receptor immunocytochemical assay to aspirates from mammographically guided fine needle biopsy of nonpalpable breast lesions. South Med J 1991;84:857-61.
16. Skoog L, Humla S, Isaksson S, Tani E. Immunocytochemical analysis of receptors for estrogen and progesterone in fine-needle aspirates from human breast carcinomas. Diagn Cytopathol 1990;6:95-8.
17. Nishimura R, Aogi K, Yamamoto T et al. Usefulness of liquid-based cytology in hormone receptor analysis of breast cancer specimens. Virchows Arch 2011;458:153-8.
18. Gong Y, Sun X, Michael CW et al. Immunocytochemistry of serous effusion specimens: a comparison of ThinPrep vs cell block. Diagn Cytopathol 2003;28:1-5.